-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
China Pharma Holdings, Inc. annual/quarterly Depreciation, Depletion and Amortization history and growth rate from Q1 2011 to Q1 2023.
- China Pharma Holdings, Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2023 was $680K, a 4.72% decline year-over-year.
- China Pharma Holdings, Inc. annual Depreciation, Depletion and Amortization for 2023 was $2.75M, a 1.97% increase from 2022.
- China Pharma Holdings, Inc. annual Depreciation, Depletion and Amortization for 2022 was $2.7M, a 12.5% decline from 2021.
- China Pharma Holdings, Inc. annual Depreciation, Depletion and Amortization for 2021 was $3.09M, a 15.2% increase from 2020.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)